Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular ...
Jan 14 (Reuters) - Eli Lilly's (LLY.N), opens new tab stock ... Bhanvi Satija reports on pharmaceutical companies and the healthcare industry in the United States. She has a postgraduate degree ...
6d
In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback